10X Genomics (TXG) PT Lowered to $18 at Morgan Stanley
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $57.99 +3.39%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on 10X Genomics (NASDAQ: TXG) to $18.00 (from $26.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
